Univest
Univest
  • Markets

Paras Healthcare IPO Listing: Shares Debut at 3.9% Premium on NSE and BSE, Check Share Price

  • October 28, 2026
  • Posted by: Neeraj Pandey
  • Category: News
No Comments
Paras Healthcare IPO Listing: Shares Debut at 3.9% Premium on NSE and BSE, Check Share Price

Paras Healthcare lists at Rs 720 on NSE and BSE, up 3.9%. Issue price Rs 693. Subscribed about 2.34 times. Issue size Rs 1,450 Cr.

Quick Answer

The Paras Healthcare IPO listing today saw the stock debut at Rs 720 on both the NSE and BSE, a 3.9 percent premium over the Rs 693 issue price. Anyone checking the Paras Healthcare share price today will find a modest listing gain of Rs 27 per share for a North India hospital chain whose IPO was subscribed only about 2.34 times.

Paras Healthcare IPO Listing Today: The IPO closed subscription on 23 October 2026 at about 2.34 times overall. Here is a recap of the offer, the terms of the Paras Healthcare IPO listing, and how the stock traded once it opened on 28 October.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Paras Healthcare IPO Listing: Issue Details
  • Paras Healthcare IPO Listing Price and Performance
  • About the Paras Healthcare IPO
  • Paras Healthcare Financials
  • FAQs
    • What was the Paras Healthcare IPO listing price?
    • Was the Paras Healthcare IPO listing a premium or a discount?
    • How much was the Paras Healthcare IPO subscribed?
    • What is the issue price of the Paras Healthcare IPO?
    • What is the lot size of the Paras Healthcare IPO?
    • Who is the registrar for the Paras Healthcare IPO?
    • What does Paras Healthcare do?
    • Where can I check the Paras Healthcare share price today?
    • Should I hold shares after the Paras Healthcare IPO listing?

Paras Healthcare IPO Listing: Issue Details

Paras Healthcare raised about Rs 1,450 crore through a book built issue of 2,09,23,520 shares in a price band of Rs 660 to Rs 693 per share. It was a mix of a Rs 500 crore fresh issue of 72,15,007 shares and a Rs 950 crore offer for sale of 1,37,08,513 shares. The shares listed on the NSE and BSE on 28 October 2026. Bidding ran from 21 to 23 October 2026.

Particular Detail
Allotment Date 26 October 2026
IPO Open Date 21 October 2026
IPO Close Date 23 October 2026
Refund Initiation 27 October 2026
Issue Size About Rs 1,450 crore (Rs 500 crore fresh issue plus Rs 950 crore offer for sale)
Lot Size 21 shares (minimum retail application Rs 14,553)
Price Band Rs 660 to Rs 693 per share
Issue Type Book Built Issue
Lead Managers JM Financial, BofA Securities India and Nuvama Wealth Management
Registrar MUFG Intime India Private Limited
Listing At NSE and BSE
Listing Date 28 October 2026

Check Live Stock Data on the Univest Screener

Paras Healthcare IPO Listing Price and Performance

Shares of the Paras Healthcare IPO listing opened at Rs 720 on both exchanges, a gain of Rs 27, or 3.9 percent, over the Rs 693 issue price. A retail investor applying for one lot of 21 shares had put in Rs 14,553, so the paper gain at the listing price works out to about Rs 567 per lot. For the smallest HNI application of 14 lots, or 294 shares, the gain is about Rs 7,938. The stock edged to Rs 723.10 shortly after opening, in line with the lukewarm subscription.

About the Paras Healthcare IPO

Paras Healthcare operates hospitals under the Paras Health brand and was founded in 1987. It runs eight hospitals with 2,211 beds across North India, Bihar and Jharkhand, with cardiac, oncology, neuro, gastro, orthopaedic and renal care making up about 75 percent of FY26 revenue. It plans a 300 bed hospital in Gurugram and a 500 bed hospital in Ludhiana. Dharminder Kumar Nagar is the promoter, and he and Commelina sold shares in the offer. JM Financial, BofA Securities India and Nuvama were the lead managers. Investors weighing the Paras Healthcare IPO listing should note that about Rs 376 crore of the fresh issue goes to repaying debt.

Download the Univest iOS App or Univest Android App to track Paras Healthcare live share price after the Paras Healthcare IPO listing and get daily stock recommendations.

Paras Healthcare Financials

Here is how the company has performed financially, useful context for anyone checking the Paras Healthcare share price today after the Paras Healthcare IPO listing.

Year Ended 31 Mar 2026 (Rs cr.) 31 Mar 2025 (Rs cr.) 31 Mar 2024 (Rs cr.)
Total Income 1,628.78 1,314.21 1,151.02
EBITDA 335.58 156.46 154.41
Profit After Tax 43.83 (57.98) (15.33)
Total Borrowings 1,393.86 1,232.12 923.92

Explanation
Total income rose about 24 percent in FY26 to Rs 1,628.78 crore and the company turned a profit of Rs 43.83 crore after losses of Rs 57.98 crore in FY25 and Rs 15.33 crore in FY24. Borrowings kept climbing to Rs 1,393.86 crore, and the issue priced the shares at about 38 times post issue earnings, so the modest gain after the Paras Healthcare IPO listing fits the risks.

Grey market premium (GMP) is an unofficial, unregulated indicator for the Paras Healthcare IPO that is not endorsed by SEBI, NSE, or BSE. Investors looking for indicative GMP data around the Paras Healthcare IPO listing can go through other relevant sources, though such figures should never be the sole basis for an investment decision.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs

What was the Paras Healthcare IPO listing price?

Ans. Paras Healthcare shares listed at Rs 720 on both the NSE and BSE, a 3.9 percent premium over the Rs 693 issue price.

Was the Paras Healthcare IPO listing a premium or a discount?

Ans. It was a modest premium listing, with the stock opening Rs 27 above the issue price.

How much was the Paras Healthcare IPO subscribed?

Ans. The IPO was subscribed about 2.34 times overall by the close of bidding on 23 October 2026, with the QIB portion at about 3.25 times and retail at about 2.10 times.

What is the issue price of the Paras Healthcare IPO?

Ans. The price band was Rs 660 to Rs 693 per share, and the issue price was fixed at the upper end, Rs 693.

What is the lot size of the Paras Healthcare IPO?

Ans. The lot size was 21 shares, and a retail investor needed Rs 14,553 for one lot at the upper end of the band.

Who is the registrar for the Paras Healthcare IPO?

Ans. MUFG Intime India Private Limited is the registrar.

What does Paras Healthcare do?

Ans. Paras Healthcare operates a chain of eight hospitals in North India, Bihar and Jharkhand under the Paras Health brand.

Where can I check the Paras Healthcare share price today?

Ans. You can check the Paras Healthcare share price today on the NSE and BSE platform, or through the Univest platform.

Should I hold shares after the Paras Healthcare IPO listing?

Ans. That depends on your own risk appetite and time horizon. Worth weighing the return to profit and bed expansion plans against high borrowings and a rich valuation before deciding whether to hold or book profit after the Paras Healthcare IPO listing.



Listing Today
Author: Neeraj Pandey
Neeraj Pandey is a Financial Content Writer at Univest, covering Indian equity markets with a specialisation in quarterly earnings previews and analyst consensus analysis. His published work tracks Q4 FY26 results across 10+ sectors — from IT heavyweights like Infosys and TCS to PSUs like Coal India and Balmer Lawrie, and mid-caps like Neuland Laboratories, MCX, and Whirlpool of India. His writing approach is data-first: every article anchors on NSE/BSE filings, analyst consensus estimates (revenue, PAT, EBITDA margins), 52-week price context, and YoY/QoQ comparisons — giving retail investors the same structured framework institutional desks use before an earnings event. He combines SEO-optimised structure with rigorous data sourcing, ensuring each preview ranks for investor search intent while meeting SEBI editorial standards. All articles are reviewed by Univest's in-house equity research team, led by Ankit Jaiswal, Senior Equity Research Analyst, to meet SEBI editorial standards.

Leave a Reply Cancel reply